Company Overview
Company Name
City Therapeutics
Address
399 Binney St, Cambridge, MA, 02142, United States
Website
citytx.comApprox. Annual Revenue
$22.0M
Employees
120
Established
2006
About City Therapeutics
City Therapeutics is a biopharmaceutical company based in Cambridge, Massachusetts, focused on developing next-generation RNA interference (RNAi) therapeutics. The company's mission is to unlock the transformative potential of RNAi to address a wide range of diseases by engineering more potent and efficient small interfering RNA (siRNA) molecules and improving their delivery to target tissues.
Business Profile
Read from the City Therapeutics website on Oct 11, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 8/10 · Clear and professional layout; Recent press releases from 2026; Detailed company information and leadership bios
City Therapeutics is hiring
Open roles listed on their website as of Oct 11, 2026.
- Senior Director, Clinical Development (Medical Director)
- Senior Director, Assistant Corporate Controller
- Associate Director, Clinical Pharmacology
- Associate Director, Toxicology (Nonclinical Safety Evaluation)
Hiring in: Clinical, Finance, Management
View careers page →Biotech & Life Sciences Companies near Cambridge, MA
- Alkeus Pharmaceuticalsalkeuspharma.com
- SerenaGroupserenagroups.com
- Clear Creek Bioclearcreekbio.com
- Marengo Therapeuticsmarengotx.com
- Iterative Healthiterative.health
- Spero Therapeuticssperotherapeutics.com
- Vaxessvaxess.com
- Boston Pharmaceuticalsbostonpharmaceuticals.com
- Blueprint Medicinesblueprintmedicines.com
- Broad Institutebroadinstitute.org
Frequently Asked Questions about City Therapeutics
Categories
Technologies Used
'%20fill='%23000000'%3e%3cg%20id='icons'%20transform='translate(56.000000,%20160.000000)'%3e%3cpath%20d='M102.8695,7446.25504%20C101.3625,7444.73916%2098.9185,7444.73916%2097.4115,7446.25504%20L91.2705,7452.43224%20C90.8935,7452.81045%2090.8935,7453.42505%2091.2705,7453.80428%20C91.6475,7454.1835%2092.2585,7454.1835%2092.6355,7453.80428%20L98.7755,7447.62809%20C99.5285,7446.86964%20100.7515,7446.86964%20101.5045,7447.62809%20C102.2585,7448.38552%20102.2585,7449.61473%20101.5045,7450.37317%20L95.4825,7456.43066%20C96.2355,7457.1881%2097.4575,7457.1881%2098.2115,7456.43066%20L102.8695,7451.74521%20C104.3765,7450.22933%20104.3765,7447.77092%20102.8695,7446.25504%20M100.8225,7448.31411%20C100.4455,7447.93488%2099.8345,7447.93488%2099.4575,7448.31411%20L93.3175,7454.49029%20C92.5635,7455.24874%2091.3415,7455.24874%2090.5885,7454.49029%20C90.2115,7454.11107%2089.6005,7454.11107%2089.2235,7454.49029%20C88.8465,7454.86952%2088.8465,7455.48412%2089.2235,7455.86233%20C90.7305,7457.37922%2093.1745,7457.37922%2094.6825,7455.86233%20L100.8225,7449.68615%20C101.1995,7449.30793%20101.1995,7448.69232%20100.8225,7448.31411%20M98.7755,7442.13691%20C97.2685,7440.62103%2094.8245,7440.62103%2093.3175,7442.13691%20L87.1765,7448.31411%20C86.8005,7448.69232%2086.8005,7449.30793%2087.1765,7449.68615%20C87.5535,7450.06537%2088.1645,7450.06537%2088.5415,7449.68615%20L94.6825,7443.50996%20C95.4355,7442.75151%2096.6575,7442.75151%2097.4105,7443.50996%20C97.7875,7443.88918%2098.3985,7443.88918%2098.7755,7443.50996%20C99.1525,7443.13073%2099.1525,7442.51613%2098.7755,7442.13691%20M96.7285,7444.19598%20C96.3515,7443.81675%2095.7405,7443.81675%2095.3645,7444.19598%20L89.2235,7450.37317%20C88.4695,7451.13061%2087.2485,7451.13061%2086.4945,7450.37317%20C85.7405,7449.61473%2085.7405,7448.38552%2086.4945,7447.62708%20L92.5175,7441.56959%20C91.7635,7440.81114%2090.5415,7440.81114%2089.7875,7441.56959%20L85.1295,7446.25504%20C83.6235,7447.77092%2083.6235,7450.22933%2085.1295,7451.74521%20C86.6375,7453.2621%2089.0805,7453.2621%2090.5885,7451.74521%20L96.7285,7445.56902%20C97.1055,7445.1898%2097.1055,7444.5752%2096.7285,7444.19598'%20id='squarespace-[%23132]'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
%20--%3e%3csvg%20version='1.1'%20id='st_x5F_cc_x5F_app_x5F_RGB.svg'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%20240.0004%20234.0004'%20style='enable-background:new%200%200%20240.0004%20234.0004;'%20xml:space='preserve'%3e%3cstyle%20type='text/css'%3e%20.st0{fill:url(%23SVGID_1_);}%20.st1{fill:%23FFFFFF;}%20%3c/style%3e%3clinearGradient%20id='SVGID_1_'%20gradientUnits='userSpaceOnUse'%20x1='119.9997'%20y1='234.0002'%20x2='119.9997'%20y2='0.0002'%3e%3cstop%20offset='0'%20style='stop-color:%23201F21'/%3e%3cstop%20offset='1'%20style='stop-color:%23313131'/%3e%3c/linearGradient%3e%3crect%20x='-0.0003'%20y='0.0002'%20class='st0'%20width='240'%20height='234'/%3e%3cg%3e%3cpath%20class='st1'%20d='M132.24969,97.95853c-5.60328,18.77988-10.28088,36.91208-15.88416,54.63138%20c-3.18081,9.99579-6.66385,19.53729-11.05544,25.59485c-4.84678,6.81497-13.93402,13.32771-24.83743,13.32771%20c-7.72443,0-15.29683-3.63509-15.29683-11.66174c0-4.99789,5.14901-9.69264,9.23837-9.69264%20c2.42339,0,3.63508,1.36282,4.24046,2.42339c3.7862,6.81497,7.42128,10.75229,9.08724,10.75229s3.02878-2.27135,5.7544-12.1151%20l19.82331-73.26013H99.08337c-1.06058-3.18081,0.45427-7.11812,2.27135-7.87554h14.23625%20c2.72562-8.7841,5.92356-17.60862,10.46719-25.63529c6.81497-12.26713,17.7193-21.95976,32.71205-21.95976%20c11.3586,0,16.05333,5.45216,16.05333,12.41917c-0.15111,7.42036-6.66293,11.20656-9.69263,11.20656%20c-2.42247,0-3.63416-1.81709-4.39159-4.39159c-2.57451-9.69263-5.90643-12.57029-7.87555-12.57029%20c-1.9682,0-4.99789,3.63416-8.3289,11.20656c-4.3925,9.54151-7.28729,19.72977-10.01291,29.72464h17.26501%20c1.05966,2.12023,0.15112,6.66385-2.42339,7.87554H132.24969z'/%3e%3c/g%3e%3c/svg%3e)
Social Profiles
Key Decision Makers
Cindy Xia VP, Non-Clinical Development